Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Opioids 100613013235-phpapp02
1. OPIOIDSDR CHANDRA SEKHAR BEHERA
PG 2ND YEAR ANAESTHESIOLOGY
The Magic within The Flower of Joy
Opium poppies are white flowers that thrive in
the dry, warm
climate of southern Asia. This field was grown
for
pharmaceutical purposes.
Saturday, June 15, 2013 1
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
2. OPIUM
Source plant(s) Papaver somniferum
Part(s) of plant sap
Geographic origin Indochina Region
Active ingredients Morphine, Codeine
Main producers Afghanistan (primary), Northern India, Thailand, Laos, Myanmar, Mexico, Colombia, Hungary
Main consumers worldwide (#1: U.S.)
Wholesale price $3,000 per kilogram
Retail price $16,000 per kilogram
Saturday, June 15, 2013 2
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
3. HISTORY
first undisputed reference to "poppy juice" is found in the writings of Theophrastus in the
third century B.C.
opium derived from the Greek word for "juice"
obtained from the poppy Papaver sominiferum
Arabian physicians were well versed in its uses and introduced the plant to the Orient
Paracelsus, circa 1500, repopularised the drug in Europe, where it had fallen out of favor
due to toxicity
18th century opium smoking became popular in the Orient and its availability in Europe led
to considerable abuse
Saturday, June 15, 2013 3
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
4. HISTORY
opium contains
more than 20
alkaloids
1806, Sertürner
isolated a pure
substance in
opium, which he
named morphine
•after Morpheus, the
Greek god of dreams
isolation of other
alkaloids soon
followed
•codeine in 1832 and
papaverine in 1848
by the middle of the
19th century, use of
the pure alkaloids
rather than crude
opium was
becoming
widespread
Saturday, June 15, 2013 4
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
5. HISTORY
problems of widespread addiction led
to the search for a morphine antagonist
in 1951 nalorphine was used in the RX of
morphine overdose
at the same time, the analgesic effects
stimulated the development of a
number of new drugs; including
naloxone, pentazocine, butorphanol etc.
Saturday, June 15, 2013 5
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
6. HISTORY
researchers concluded that the interactions and differences between morphine and its
derivatives could only be explained by the existence of more than one receptor type
® receptor dualism(Martin 1967)
1973 : 3 groups of workers described saturable, stereospecific binding sites (following
work by Goldstein)
1975 : the enkephalins were isolated from pig brain
since then researchers have shown that there are three distinct families of endogenous
opioid peptides and multiple categories of opioid receptors
Saturday, June 15, 2013 6
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
7. INTRODUCTION
All natural and semi synthetic opium alkaloid derivatives
synthetic agents and other drug whose upload-like effects are
blocked by naloxone-non selective opioid receptor antagonist
SOURCE-Opium poppy
CONSTITUENTS-Analgesic components-
Morhine,codeine,Thebaine
Nonanalgesic component-papaverine
Saturday, June 15, 2013 7
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
8. CLASSIFICATIONS
Classification
Natural Alkaloids of Opium
phenanthrenes morphine, codeine, thebaine
benzylisoquinolines papaverine, noscapine
Semi-synthetic Derivatives diacetylmorphine (heroin)
hydromorphone, oxymorphone
hydrocodone, oxycodone
Synthetic Derivatives
phenylpiperidines pethidine, fentanyl, alfentanyl, sufentnyl
benzmorphans pentazocine, phenazocine, cyclazocine
propionanilides methadone
morphinans levorphanol
Saturday, June 15, 2013 8
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
10. ENDORPHINS
highest concentrations of b-endorphin occur
in
• pituitary gland
• basal, medial, and arcuate regions of the hypothalamus
• long axoned neurons which synapse in the
septum, periaqueductal grey and thalamic regions of
the midbrain
unclear whether b-endorphin exists
functionally in the spinal cord
11. ENKEPHALLINS
widely distributed throughout the CNS,
• limbic system (amygdaloid & septal nuclei)
• medial thalamic nuclei
• periaqueductal grey matter & midline reticular formation in the midbrain
• the periventricular grey areas in the medulla
• laminae I, II & IV of the spinal cord (substantia gelatinosa)
• the area postrema (CTZ)
NB: all of which are involved in the reception of afferent
nociceptive information
Saturday, June 15, 2013 11
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
12. STRUCTURE ACTIVITY
complex structures usually with a number of optical
isomers, of which only the l-isomer is most active
structural similarities within this class include,
• structure conforms to a "T-shape"
• a tertiary, positively charged basic nitrogen
• a quaternary carbon, C13 in morphine,
• separated from the basic N by an ethane (-CH2-CH2-) chain
• attached to a phenyl group (phenol, ketone)
• presence of an aromatic ring
• centre is 0.455 nm from the nitrogen atom
Saturday, June 15, 2013 12
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
15. Schematic of Presynaptic Opiate
actionSaturday, June 15, 2013 15
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
16. RECEPTORS
Type Effects Agonist Antagonist
1
Supraspinal
analgesia
Miosis
Euphoria
Abuse
potential
Morphine
Naloxone
Pentazocine
naltrexone
2
Bradycardia
Respiratory
depression
GIT motility
As above As above
Saturday, June 15, 2013 16
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
17. RECEPTORS
Receptors
Type Effects Agonist Antagonist
Kappa
Spinal
analgesia
Pentazocine Naloxone
Sedation ketacycline Naloxone
Delta
Spinal
analgesia
Pentazocine Naloxone
Dysphoria D-leu-enkephalin ?
Sigma Mydriasis ?ketamine ?
Hallucination
s
N-
allylnormethazocine
?
Saturday, June 15, 2013 17
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
18. OPIOID RECEPTORS
Mu (morphine) MOP OP3
Delta DOP OP1
Kappa KOP OP2
Nociceptin orphaninFQ NOP orphan
Saturday, June 15, 2013 18
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
19. RECEPTOR ACTIVITY
the actions of opioids are generally described with
reference to only 3 types of receptors
• ® µ, k, & d
on the basis of these receptors, drugs can be
divided into 4 groups,
• agonists
• antagonists
• agonist-antagonists
• partial agonists
Saturday, June 15, 2013 19
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
20. TERMINOLOGY
PURE AGONIST-Has
affinity for binding plus
efficacy
PURE ANTAGONIST-Has
affinity for binding but
no efficacy blocks action
of exogenous and
endogenous ligands
MIXED AGONIST-
ANTAGONIST-Produces
agonist effect at one
receptor and antagonist
effect on another
PARTIAL AGONIST-Has
affinity for binding but
low efficacy
Saturday, June 15, 2013 20
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
22. PARTIAL AGONISTS
drugs that produce a less than
maximal response
and, therefore, have a low
intrinsic activity are called partial
agonists
these display certain
pharmacological features,
•the slope of the dose-response curve is
less than that of a full agonist
•the dose response curve exhibits a ceiling
with the maximal response below that
obtainable by a full agonist
•partial agonists are able to antagonise
the effects of large doses of full agonists
Saturday, June 15, 2013 22
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
23. PARTIAL AGONISTS
NB: this is a
schematic
representation to
illustrate the
differential effects of
various opioid agents;
the actual interactions
responsible for
agonist / partial
agonist activity are
uncertain
Saturday, June 15, 2013 23
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
27. ANALGESIA
µ-receptors are located on the terminal axons of primary
afferents within laminae I & II (substantia gelatinosa) of the
spinal cord (+ spinal nucleus of the trigeminal nerve)
• decrease the presynaptic release of neurotransmitters, predominantly
substance P
enkephalinergic interneurones in the dorsal horn are
predominantly inhibitory to the soma of cells in the deeper
laminae IV & V
• morphine is inactive at these sites
• met-ENK, a d-receptor agonist inhibits neuronal firing
• both µ & d receptors inhibit spinal transmission of pain
Saturday, June 15, 2013 27
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
28. ANALGESIA
stimulation of pain fibres activates enkephalinergic neurones in
the spinal cord, which play a role in the "gating" of pain and in
mediating the effect of descending medullary analgesic pathways
further modulation of nociception involves the periventricular and
periaqueductal grey matter
• direct microinjections of morphine, or electrical stimulation produce analgesia
which can be blocked by naloxone
• stimulation at this level results in barrages of impulses travelling in descending
pathways to the dorsal horns of the spinal cord
Saturday, June 15, 2013 28
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
29. AGE EFFECTS
radioligand-receptor studies have shown a
marked and widespread reduction in mu and
delta receptor densities with age
this work supports clinical studies which
show a far greater correlation between dose
requirements and age, cf. body weight
this is a specific effect, as similar studies
show an increase in benzodiazepine
receptors
Saturday, June 15, 2013 29
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
30. PHARMACODYNAMICS
“What the drug does to the body”
This means:
• Receptor and cellular level
And..
• Organ system effects
• Such as
• CVS
• CNS
• Resp
• GIT
• Genitourinary
• Placenta/Foetus
• etcSaturday, June 15, 2013 30
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
32. CNS
EEG
•High voltage,slow delta
waves
SSEP’s
• velocity
and
amplitude
Pupils
•Miosis
CTZ
•N & V with
help from
vestibular
nucleus
Saturday, June 15, 2013 32
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
35. OTHER CNS EFFECTS
•nausea & vomiting
•direct stimulation of the CTZ in the area postrema of the
medulla
•also stimulated by apomorphine, a dopaminergic agonist
•may RX with phenothiazines which posses a dominant
dopamine-blocking action
•up to 15-40% of ambulatory patients, may be a vestibular
component
•miosis
•caused by most mu & kappa receptor agonists
•stimulation of the Edinger-Westphal nucleus
•pinpoint pupils being pathognomic of opioid overdose
2
important
excitatory
effects
include,
Saturday, June 15, 2013 35
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
36. MUSCLE RIGIDITY
high doses may produce rigidity, characterised by increasing
muscle tone progressing to severe stiffness, particularly in
the thoracic and abdominal muscles
appears to be a higher incidence with
• large boluses and rapid infusions
• the elderly
• concomitant use of N2O
• with alfentanyl
Saturday, June 15, 2013 36
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
37. CEREBRAL BLOOD FLOW
the opioids generally produce a modest (~ 10-15%)
decrease in CMRO2 and ICP
in contrast to the volatile agents they are cerebral
vasoconstrictors
this occurs even in the presence of nitrous oxide
Guy Ludbrook thinks they uncouple CBF & CMRO2
Saturday, June 15, 2013 37
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
38. CEREBRAL BLOOD FLOW
morphine 1-3 mg/kg + 70% N2O
• insignificant changes in CBF and CMRO2
fentanyl 100 µg/kg + 70% N2O
• dose related decreases in,
• CBF to a maximum of 50%
• CMRO2 to a maximum of 35%
similar changes seen with sufentanyl and alfentanyl
all of these agents decrease CSF formation while not affecting reabsorption
Saturday, June 15, 2013 38
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
40. CVS EFFECTS
morphine & related opioids produce minimal
effects in normal supine subjects
however they do produce,
• peripheral vascular dilation
• reduced peripheral resistance
• depression of the baroreceptor reflexes
® postural hypotension in erect subjects
Saturday, June 15, 2013 40
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
41. CVS EFFECTS
these effects are produced by a number
of mechanisms,
• release of histamine
• a direct centrally mediated reduction in
sympathetic tone - reversed by naloxone
• a vagal induced bradycardia
• direct and indirect (PaCO2) mediated vasodilatation
• splanchnic sequestration of blood
Saturday, June 15, 2013 41
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
42. CVS:BRADYCARDIA
all µ-receptor agonists (except pethidine) HR
risk of bradycardia / asystole on induction,
• Ca++-channel, or b-adrenergic blockers
• concomitant use of benzodiazepines
• muscle relaxants without vagolytic properties (vecuronium)
• muscle relaxants with vagotonic properties (succinylcholine)
• vagal stimuli (laryngoscopy)
• rapid administration of the opioid
Saturday, June 15, 2013 42
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
44. RESPIRATORY
all µ-receptor agonists
dose dependent depression
of respiration,
• brainstem sensitivity to CO2
• slope of the CO2-ventilation response curve
• apnoeic threshold
• hypoxic drive to respiration
•carotid body chemoreception is virtually
abolished
• pontine & medullary centres involved in
rhythmic respiration
they do not affect hypoxic pulmonary
vasoconstriction
Saturday, June 15, 2013 44
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
45. RESPIRATORY
delayed respiratory depression has been reported with
most of the opioids
• morphine, pethidine, fentanyl, alfentanyl, and sufentanyl
exact cause is unclear, possibly
• secondary plasma drug peaks
• sequestration of ~ 20% of fentanyl in the stomach
• large peripheral storage compartments (skeletal muscle)
• supplemental analgesics and other medications
• lack of nociceptive stimulation
Saturday, June 15, 2013 45
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
46. FACTORS INCREASING RESPIRATORY
DEPRESSION
Factors Increasing Opioid Respiratory Depression
Increasing dose
Intermittent bolus vs. continuous infusion
Increased brain penetration, or drug delivery
decreased distribution, low CO
increased unionised fraction (respiratory alkalosis)
Decreased reuptake from the brain (respiratory alkalosis)
Decreased drug clearance
decreased liver blood flow (abdominal surgery)
intrinsic liver disease
Secondary plasma drug peaks
peripheral storage compartments, lung, fat, muscle
sequestration in the stomach
Increased ionised fraction at the receptor site (respiratory acidosis)
Sleep
Increasing age ( 60 yrs) and neonates
Metabolic alkalosis
Factors Increasing Opioid Respiratory Depression
Increasing dose
Intermittent bolus vs. continuous infusion
Increased brain penetration, or drug delivery
decreased distribution, low CO
increased unionised fraction (respiratory alkalosis)
Decreased reuptake from the brain (respiratory alkalosis)
Decreased drug clearance
decreased liver blood flow (abdominal surgery)
intrinsic liver disease
Secondary plasma drug peaks
peripheral storage compartments, lung, fat, muscle
sequestration in the stomach
Increased ionised fraction at the receptor site (respiratory acidosis)
Sleep
Increasing age ( 60 yrs) and neonates
Metabolic alkalosis
Saturday, June 15, 2013 46
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
49. NEUROENDOCRINE
Generally decreses the responsivness of the hypothalamus
causing Decrese in temp
Decrease relese of GnRH
Increse in GH & Prolactin
May give rise to mild drug induced SIADH
Saturday, June 15, 2013
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
49
50. Tolerance
result from uncoupling of the drug-receptor effect
• decrease in the number of receptors
• reduction of their affinity for a given agonist, and
• subcellular uncoupling of the receptor and second messenger
there is little cross-tolerance between different receptor
groups
high affinity agonists, ie. those with the greatest
receptor reserve, produce least tolerance
Saturday, June 15, 2013 50
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
51. TOLERANCE TO OPIOIDS
Components of different types of tolerance may be present
Some effects of opioids are more susceptible to tolerance than
others:
Rapidly occurring:
• Nausea and vomiting
• Sedation
• Euphoria
• Respiratory depression
Less affected by tolerance:
• Constipation
• MiosisSaturday, June 15, 2013 51
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
52. PHARMACOKINETICS
Remember this means:
• Absorption
• Bioavailability
• Distribution
• Protein Binding
• Metabolism
• t½
• Metabolites
• Excretion
Saturday, June 15, 2013 52
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
53. IMPORTENCE OF KINETICS IN
OPIOIDS
Questions regarding infusions, repeat dosing, context sensitive half-
life, onset times, etc relate to the individual drugs and their kinetics
Lipid solubility allows access across biological membranes (including
BBB). Tends to result in faster effect-site equilibration.
pKa important – opioids are weak bases. A lower pKa means a higher
proportion of drug is unionised (or in its lipid soluble form)
High plasma protein binding restricts volume of distribution
Saturday, June 15, 2013 53
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
54. IDEAL KINETICS FOR OPIOID
INFUSION
Ideal properties:
•Short elimination half life
•Offset by metabolism or excretion, not
redistribution
•No active metabolites
•Tight concentration – effect relationship
Saturday, June 15, 2013 54
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
57. MORPHINE
• Poor lipid solubility and vd-3-5l/kg
• Conversion of phamacologicaly active
metabolite m6g
• Slow onset and prolong duration
• Pka-8.0 ,
• % unionised at pH-7.4-23
• %plasma protein binding-35
• Clearance-15-30ml/min/kg
Saturday, June 15, 2013
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
57
58. INDICATIONS
• Morphine can be used as an analgesic in hospital settings to relieve:
– pain in myocardial infarction
– pain in sickle cell crisis
– pain associated with surgical conditions, pre- and postoperatively
– pain associated with trauma
– severe chronic pain, e.g., cancer
– pain from kidney stones (renal colic, ureterolithiasis)
– severe back pain
• Morphine can also be used:
– as an adjunct to general anesthesia
– in epidural anesthesia or intrathecal analgesia
– for palliative care (i.e., to alleviate pain without curing the underlying reason for it, usually
because the latter is found impossible)
– as an antitussive for severe cough
– as an antidiarrheal in chronic conditions (e.g., for diarrhea associated with AIDS, although
loperamide (a non-absorbed opioid acting only on the gut) is the most commonly used opioid
for diarrhea).
Saturday, June 15, 2013
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
58
59. CONTRADICTIONS
• The following conditions are relative contraindications for
morphine:
• acute respiratory depression
• renal failure (due to accumulation of the metabolites
morphine-3-glucuronide and morphine-6-glucuronide)
• chemical toxicity (potentially lethal in low tolerance
subjects)
• raised intracranial pressure, including head injury (risk of
worsening respiratory depression)
• Biliary colic.
• Although it has previously been thought that morphine was
contraindicated in acute pancreatitis, a review of the
literature shows no evidence for this.
Saturday, June 15, 2013
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
59
61. HEROIN
Crosses blood-brain barrier
more rapidly than morphine
2-4 X greater potency than
morphine
Converted to morphine
Saturday, June 15, 2013 61
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
62. HYDROMORPHONE
About 8-10X potency of
morphine
Slightly shorter duration
than morphine
available as suppository
Saturday, June 15, 2013 62
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
64. OXYCODEINE
About 10X potency of codeine
Also metabolized by CYP450-2D6
Controlled release formulation
(OxyContin)
Saturday, June 15, 2013 64
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
66. PARTIAL AGONIST-BUPRENORPHINE
Partial agonist at
mu receptors
Partial agonist at
kappa3 receptors
Antagonist at
kappa1 receptors
Lower efficacy
analgesic than
morphine
Slow dissociation
from receptor
hence naloxone
resistent
Saturday, June 15, 2013 66
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
68. MEPERIDINE
About 1/8th potency of morphine
shorter duration
fewer smooth muscle spasms than
morphine
No meiosis
biotransformed to a toxic metabolite
that builds up and can cause seizures.
Synergistic with Gila monster venom
Saturday, June 15, 2013 68
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
69. FENTANYL
80 - 100 x
potency of
morphine
fast
onset, short
duration
used i.v. for
anesthesia
available as
patch
available as
oral slow
release
device.
Saturday, June 15, 2013 69
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
70. USES
• Extensivly used for anaesthesia and analgesia in
both operating room and ICUsettings
• Used with benzodiazepines and midazolam in
endoscopic procedure,cardiac
catheterisation, oral surgeries
• Widely used as tansdermal patches to alleviate
pain like in cancer
• Fentanyl given in intrathecaly as spinal
anaesthesia and epiduraly as epidural anaesthsia
and anagesia
Saturday, June 15, 2013
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
70
71. SULFENTANIL
Exteremly lipid soluble-rapid effect site equilibration and
rapid redistribution of the drug leading to termination of
effect
High plasma protein binding lead to less Vd than fentanyl
Accumulate in prolong infusion become longer than
alfentnyl at 8 hrs
Saturday, June 15, 2013 71
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
72. ALFENTNIL
Low pKa-very fast equilibaration time with CNS because bulk of
drug in unionised form &cross BBB even though not lipid soluble
as other fentanyl congeners
Low Vd-due to low lipid solubility and high protein
binding.Redistribution is not a significant in offset-requires
metabolism.this explains longer CSHT than sulfentanil until 8 hrs
Metabolised by cyt p450 3A4-Inducible and explains variability
seen
Saturday, June 15, 2013 72
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
73. REMIFENTANIL
Highly unionised-rapid onset of effect
Rapid clearance and small Vd-effect terminated by elimination
Metabolite GR90291 has only 1/4600 th activity –unlikely to produce
effect after infusion
Tight concentration-effect relationship
Very well suited for infusion
Saturday, June 15, 2013 73
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
74. METHADONE
Potency similar to morphine for i.v.
administration, but 4 x more potent
orally
long plasma half-life
used in treatment of narcotic
dependence
Duration of action increases with
repeated use
Saturday, June 15, 2013 74
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
75. LAAM
Extremely long plasma
half-life (>72 hr)
Suppresses opiate
withdrawal for 4-5 days
Saturday, June 15, 2013 75
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
76. TRAMADOL
These actions
are synergistic
for analgesia
α-2
adrenoceptor
agonist
NE and 5-HT
reuptake
blocker
(antidepressant)
Opioid receptor
agonist (mu and
delta)
Saturday, June 15, 2013 76
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
78. SIGNS OF OVERDOSE
Stuporous
or in
coma
Respiratory
rate
extremely
low
pinpoint
pupils
low body
temperature
flacid skeletal
muscles, jaw
relaxed
Saturday, June 15, 2013 78
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
79. NALOXONE
no analgesic activity at all
competitive antagonist at mu, kappa, and sigma receptor
displaces morphine and other OPIOID from receptor site
reverses all actions of the OPIOID and does it rather quickly
it will precipitate withdrawal
increased blood pressure
metabolized same as morphine through glucuronic acid and excreted through
kidney
82. MIXED AGONIST ANTAGONIST
Nalorphine and
cyclazocine
Pentazocine:
Talwin NX
Butorphanol
Nalbuphine
Saturday, June 15, 2013 82
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
83. NALORPHIN AND CYCLOZOCINE
Kappa3 receptor
agonists
Mu receptor
antagonists
produce
psychotomimetic
effects
produce
dysphoria
Saturday, June 15, 2013 83
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
84. PENTAZOCINE
Kappa and delta agonist
Non addictive and non euphoric
Has ceilling effect
Saturday, June 15, 2013 84
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
85. BUTORPHANOL
Kappa receptor agonist
Mu receptor
antagonist
Available as nasal spray
analgesic eq to
buprenorhine and
nalbuphine
5 X more
potent in
women than
men
Saturday, June 15, 2013 85
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
87. DEPENDENCE AND ADDICTION
Dependence: The propensity
to experience an abstinence
syndrome after
discontinuation of a drug, or
administration of an
antagonist drug. May begin
to develop from 1-2 weeks
with several doses/day.
Addiction: A chronic
condition, characterised by
the compulsive use of a
substance resultant in harm
(physical, psychological or
social) and continued use
despite that harm
Saturday, June 15, 2013 87
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
88. WITHDRAWAL
The time course is a function of the elimination half-life of the opioid
Symptoms will appear within 6 to 12 hours and reach a peak at 24 to
72 hours following cessation of a short half-life drug such as
morphine
36 to 48 hours with methadone, a long half-life drug.
The daily dose required to prevent withdrawal, when ceasing is
approximately one fourth of the previous dose.
Saturday, June 15, 2013 88
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
89. WITHDRAWAL
The onset is characterized by feelings of anxiety, nervousness and irritability
chills and hot flushes.
"wetness" including salivation, lacrimation, rhinorrhea and diaphoresis
piloerection.
At the peak, nausea, vomiting, abdominal cramps, insomnia
and, rarely, multifocal myoclonus.
90. OPIOID ANAESTHESIA
considerable debate as to whether opioids in their own right
produce anaesthesia
to date there is no study showing that opioids alone, without
muscle relaxants or other supplementation, will reliably
produce anaesthesia in humans
most studies assess the reductions in volatile MAC in animal
models, demonstrating a ceiling effect which is
subanaesthetic
Saturday, June 15, 2013 90
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
91. OPIOID ANAESTHESIA
the problems with these studies include,
• the profile of action of opioids varies considerably with
animal species, thus extrapolation to humans is not readily
achieved
• as inhibition of motor responses occur at deeper levels of
anaesthesia than unconsciousness, amnesia and analgesia,
methods requiring motor responses, eg. tail clamp
studies, underestimate opioid effect
• volatile agents inhibit descending inhibitory pain pathways
activated by the opioids, therefore may decrease the
effectiveness of the opioids
Saturday, June 15, 2013 91
DEPT OF ANAESTHESIA MKCG MEDICAL
COLLEGE
92. ANAESTHESIA
presumed specific action of the opioids would not be expected to
produce anaesthesia
postulated that the analgesia produced at subanaesthetic
concentrations and the unconsciousness produced at higher levels
may be mediated by different processes
dual mechanism hypothesis requires that in addition to the
receptor mediated effects, an opioid must be lipid soluble enough
to act as a general anaesthetic
• a biphasic response has been noted for fentanyl and sufentanyl